Deswell Industries Q4 2026 Earnings Report

Deswell Industries EPS Results

• Actual EPS: N/A
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: $0.70

Deswell Industries Revenue Results

• Actual Revenue: N/A
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Deswell Industries Announcement Details

• Quarter: Q4 2026
• Date: 6/17/2026
• Time: Before Market Opens
• Conference Call Date: N/A
• Conference Call Time: N/A

Deswell Industries (NASDAQ:DSWL) (NASDAQ: DSWL) is a China-based medical device company that designs, develops, manufactures and distributes airway management and respiratory care products. The company’s product portfolio includes laryngeal mask airways, disposable endotracheal tubes, nebulizers, oxygen therapy equipment, humidifiers and related ventilator accessories. Deswell’s devices are used in hospitals, clinics and home-care settings to support anesthesia, emergency medicine and respiratory treatment.

Founded in 2003 and headquartered in Shenzhen, Deswell operates multiple manufacturing facilities that comply with international quality standards, including FDA 510(k) clearances and CE markings for many of its devices. The company sells its products under the Deswell, Glomix and Devon brands, serving customers across Asia, North America, Europe and other global markets through direct sales teams and distribution partners.

Throughout its history, Deswell has placed emphasis on research and development, maintaining in-house engineering and testing laboratories to advance its product designs and ensure regulatory compliance. The company’s leadership team is responsible for overseeing strategic partnerships, global expansion and continuous improvement of manufacturing processes, with a focus on delivering reliable, cost-effective medical devices to healthcare providers worldwide.